Vascular Graft Market - 2022

August 2025 | 219 pages | ID: VE71B5D92741EN
DataM Intelligence

Abstracts

The Vascular Graft Market was valued at USD 2,483.29 million in 2022 and is anticipated to reach by , at a CAGR of 0.076 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Vascular Graft Market.

This report delivers a comprehensive overview of the Vascular Graft Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Vascular Graft Market. The Vascular Graft Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–.

Vascular Graft Market Scope:

By Product

• Hemodialysis Access Graft
• Endovascular Aneurysm Repair Stent Graft
• Peripheral Vascular Graft

By Raw Material

• Polyester
• Polytetrafluoroethylene (PTFE)
• Polyurethane
• Biosynthetic

By End User

• Hospitals
• Specialty Clinics
• Ambulatory Surgery Center

Key Players

• Abbott Laboratories
• Braun Melsungen AG
• Bard Peripheral Vascular Inc. (BD)
• Cardinal Health (Cordis Corporation)
• Cook Medical
• Cryolife
• Getinge Group
• LeMaitre Vascular Inc
• Medtronic PLC
• W.L. Gore & Associates Inc(LIST NOT EXHAUSTIVE)

Major Highlights

This report delivers a comprehensive overview of the Vascular Graft Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Vascular Graft Market. The Vascular Graft Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Product
3.2. Snippet by Raw Material
3.3. Snippet by End User
3.4. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Increasing incidence of cardiovascular disease
  4.1.2. Restraints
    4.1.2.1. Product failures and recalls
  4.1.3. Opportunity
    4.1.3.1. The growing geriatric population
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 ANALYSIS

6.1. Analysis of COVID-19
  6.1.1. Before COVID-19 Scenario
  6.1.2. Present COVID-19 Scenario
  6.1.3. Post COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. BY PRODUCT

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  7.1.2. Market Attractiveness Index, By Product
7.2. Hemodialysis Access Graft
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Endovascular Aneurysm Repair Stent Graft
7.4. Peripheral Vascular Graft

8. BY RAW MATERIAL

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
  8.1.2. Market Attractiveness Index, By Raw Material
8.2. Polyester
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Polytetrafluoroethylene (PTFE)
8.4. Polyurethane
8.5. Biosynthetic

9. BY END USER

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Ambulatory Surgery Center

10. BY REGION

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  10.1.2. Market Attractiveness Index, By Region
10.2. North America
  10.2.1. Introduction
  10.2.2. Key Region-Specific Dynamics
  10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
  10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.2.6.1. The U.S.
    10.2.6.2. Canada
    10.2.6.3. Mexico
10.3. Europe
  10.3.1. Introduction
  10.3.2. Key Region-Specific Dynamics
  10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
  10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.3.6.1. Germany
    10.3.6.2. The U.K.
    10.3.6.3. France
    10.3.6.4. Italy
    10.3.6.5. Spain
    10.3.6.6. Rest of Europe
10.4. South America
  10.4.1. Introduction
  10.4.2. Key Region-Specific Dynamics
  10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
  10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.4.6.1. Brazil
    10.4.6.2. Argentina
    10.4.6.3. Rest of South America
10.5. Asia-Pacific
  10.5.1. Introduction
  10.5.2. Key Region-Specific Dynamics
  10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
  10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.5.6.1. China
    10.5.6.2. India
    10.5.6.3. Japan
    10.5.6.4. Australia
    10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
  10.6.1. Introduction
  10.6.2. Key Region-Specific Dynamics
  10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
  10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. COMPETITIVE LANDSCAPE

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. COMPANY PROFILES

12.1. Abbott Laboratories*
  12.1.1. Company Overview
  12.1.2. Product Portfolio and Description
  12.1.3. Financial Overview
  12.1.4. Key Developments
12.2. Braun Melsungen AG
12.3. Bard Peripheral Vascular Inc. (BD)
12.4. Cardinal Health (Cordis Corporation)
12.5. Cook Medical
12.6. Cryolife
12.7. Getinge Group
12.8. LeMaitre Vascular Inc
12.9. Medtronic PLC
12.10. W.L. Gore & Associates Inc(*LIST NOT EXHAUSTIVE)

13. APPENDIX

13.1. About Us and Services
13.2. Contact Us